This is a discussion on Afinitor sales projections within the Managed Care Issues for Oral Drugs forum, part of the Managed Care Drug Coverage category; During the September 2009 Webinar, the following question was submitted and we’d like to open it for a general ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
|
||||
|
At least 1 analyst, Standard and Poor has predicted Afinitor to become a blockbuster (assuming at least $1B in sales), but no specific figures have been given. Additionally, Afinitor was approved at the end of 3/2009, and Novartis reported sales of $12B as of 7/2009.
Last edited by chantell.reagan : 10-19-2009 at 10:45 AM. |
![]() |
| Thread Tools | |
| Display Modes | |
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| GPs warn on internet drug sales | chantell.reagan | Other Clinical Pharmacy News | 0 | 04-23-2009 10:24 AM |
| Drug sales increase at 47-year low | chantell.reagan | Other Clinical Pharmacy News | 0 | 03-26-2009 11:05 AM |
| TNF-antibodies top biologic sales for 2008 | chantell.reagan | Biotechnology News | 0 | 03-12-2009 02:07 PM |
| Biogen's Tysabri sales disappoint Street | industry_news | Biotechnology News | 0 | 02-06-2009 01:14 PM |
| Biotech drug sales grow 12.5% in 2007 | industry_news | Biotechnology News | 0 | 06-17-2008 07:00 PM |